Abstract:Purpose The purpose of this study is to analyze clinical information and combine significant parameters to generate a predictive model and achieve a better prognosis prediction of dermatomyositis-associated interstitial lung disease with positive melanoma differentiation-associated gene 5 antibody (MDA5 + DM-ILD) and stratify patients according to prognostic risk factors appropriately. Methods We retrospectively reviewed 63 patients MDA5 + DM-ILD who were treated in our hospital from January 2018 to January 2021. Our study incorporated most clinical characteristics in clinical practice to explore the associations and predictive functions of clinical characteristics and prognosis. Student's t -test, Mann-Whitney U -test, chi-squared test, Pearson correlation analysis, Cox regression analysis, R, receiver operating characteristic curves (ROC curves), and Kaplan-Meier survival curves were performed to identify independent predictors for the prognosis of MDA5 + DM-ILD. Results In all the 63 patients with MDA5 + DM-ILD, 44 improved but 19 did not. Poor prognosis was found more frequently in patients who were older, clinically amyopathic variant of dermatomyositis (CADM), and/or with short duration, short interval of DM and ILD, long length of stay, fever, dyspnea, non-arthralgia, pulmonary infection, pleural effusion (PE), high total computed tomography scores (TCTs), ground-glass opacity (GGO), consolidation score, reticular score and fibrosis score, decreased forced vital capacity (FVC), forced expiratory volume in 1s (FEV1), albumin, A/G, glomerular filtration rate (GFR) and tumor necrosis factor α (TNFα), high titer of anti-MDA5, proteinuria, high levels of monocyte, lactate dehydrogenase (LDH), ferritin (FER), neuron specific enolase (NSE) and glucocorticoid, antibiotic, antiviral, and non-invasive positive pressure ventilation (NPPV). The multivariate Cox regression analysis demonstrated that duration, fever, PE, TCTs and aspartate transaminase (AST) were independent predictors of poor prognosis in patients with MDA5 + DM-ILD. The nomogram model quantified the risk of 400-day death as: duration ≤ 4 months (5 points), fever (88 points), PE (21 points), TCTs ≥10 points (22 points), and AST ≥200 U/L (100 points) with high predictive accuracy and convenience. The ROC curves possessed good discriminative ability for combination of fever, PE, TCTs, and AST, as reflected by the area under curve (AUC) being.954, 95% CI 0.902–1.000, and sensitivity and specificity being 84.2 and 94.6%, respectively. Conclusion We demonstrated that duration, fever, PE, TCTs, and AST could be integrated together to be independent predictors of poor prognosis in MDA5 + DM-ILD with highly predictive accuracy.

Title: MDA5 score--A Novel Lung Computed Tomography Scoring Method for Anti-Melanoma Differentiation-associated Gene 5-positive Dermatomyositis

A Novel CT Scoring Method Predicts the Prognosis of Interstitial Lung Disease Associated with Anti-Mda5 Positive Dermatomyositis

MDA5 score--A Novel Lung Computed Tomography Scoring Method for Anti-Melanoma Differentiation-associated Gene 5-positive Dermatomyositis

Radiological Characteristics of Patients with Anti-MDA5–Antibody-Positive Dermatomyositis in 18F-FDG PET/CT: A Pilot Study

A Computed Tomography Radiomics-Based Prediction Model on Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis

Application of HRCT-based radiomics to predict interstitial lung disease for juvenile dermatomyositis

A New Predictive Model for the Prognosis of MDA5+ DM-ILD

The Value of Effective Lung Ventilation Area Ratio Based on CT Image Analysis Is a New Index to Predict the Shorter Outcome of Anti-melanoma Differentiation-Associated Protein 5 Positive Dermatomyositis Associated Interstitial Lung Disease: A Single-Center Retrospective Study

Clinical Nomogram Assisting in Discrimination of Juvenile Dermatomyositis-Associated Interstitial Lung Disease.

Presence of Two Different Types of Protein-Disulfide Isomerase on Cytoplasmic and Luminal Surfaces of Endoplasmic Reticulum of Rat Liver Cells.

Clinical Significance of HScore and MS Score Comparison in the Prognostic Evaluation of Anti-Mda5-positive Patients with Dermatomyositis and Interstitial Lung Disease

The role of serum anti-m elanoma differentiation associated gene 5 antibody in the diagnosis of interstitial lung disease and judgment of prognosis in dermatomyositis and clinically amyopathic dermatomyositis patients

MDA5 Expression is Associated with TGF-β-induced Fibrosis: Potential Mechanism of Interstitial Lung Disease in Anti-Mda5 Dermatomyositis.

Forced Vital Capacity Predicts the Survival of Interstitial Lung Disease in Anti-Mda5 Positive Dermatomyositis: a Multi-Centre Cohort Study.

Clinical Characteristics and Prognostic Factors of Patients with Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis Associated Interstitial Lung Disease

Quantitative Indexes and Clinical Studies of Lung HRCT in Patients with Anti-MDA5 Antibody-positive Iims with Different Prognoses and Clinical Studies

A Nomogram Based on Clinical Factors and CT Radiomics for Predicting Anti-Mda5+ DM Complicated by RP-ILD.

Cytokeratin 19 fragment is associated with severity and poor prognosis of interstitial lung disease in anti-MDA5 antibody-positive dermatomyositis

Distribution of Anti-Melanoma Differentiation Associated Gene 5 (MDA5) IgG Subclasses in MDA5+ Dermatomyositis.

Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis.

OP0171 SINGLE-CELL IMMUNE LANDSCAPE OF AFFECTED LUNGS FROM THE PATIENTS WITH ANTI-MDA5-POSITIVE DERMATOMYOSITIS